Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  2,007 نتائج ل ""Antiparkinson Agents""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Ecofriendly micellar mediated spectrofluorimetric method for ultrasensitive quantification of the antiparkinsonian drug safinamide in pharmaceutical formulation and spiked human plasma.

  • Authors : Ibrahim EA; Pharmaceutical Analytical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City, Giza, Egypt.; Marzouk HM

Subjects: Micelles* ; Spectrometry, Fluorescence*/Spectrometry, Fluorescence*/Spectrometry, Fluorescence*/methods ; Alanine*/Alanine*/Alanine*/analogs & derivatives

  • Source: Scientific reports [Sci Rep] 2024 Jul 16; Vol. 14 (1), pp. 16460. Date of Electronic Publication: 2024 Jul 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.

  • Authors : Yi Z; Department of Pharmacy, Peking University Third Hospital, 49 North Garden Road, Haidian District, 100191, Beijing, China. .; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China. .

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/economics ; Medication Adherence*/Medication Adherence*/Medication Adherence*/statistics & numerical data

  • Source: BMC public health [BMC Public Health] 2024 Apr 30; Vol. 24 (1), pp. 1202. Date of Electronic Publication: 2024 Apr 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The effects of safinamide according to gender in Chinese parkinsonian patients.

  • Authors : Pellecchia MT; Neuroscience Section, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, 84131, Salerno, Italy. .; Picillo M

Subjects: Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/pharmacology ; Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/therapeutic use ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

  • Source: Scientific reports [Sci Rep] 2023 Nov 23; Vol. 13 (1), pp. 20632. Date of Electronic Publication: 2023 Nov 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Eltoprazine modulated gamma oscillations on ameliorating L-dopa-induced dyskinesia in rats.

  • Authors : Bi Y; Neurosurgery Center, Department of Pediatric Neurosurgery, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Wang P

Subjects: Serotonin Receptor Agonists*/Serotonin Receptor Agonists*/Serotonin Receptor Agonists*/pharmacology ; Serotonin Receptor Agonists*/Serotonin Receptor Agonists*/Serotonin Receptor Agonists*/therapeutic use ; Piperazines*/Piperazines*/Piperazines*/pharmacology

  • Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Oct; Vol. 29 (10), pp. 2998-3013. Date of Electronic Publication: 2023 Apr 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review.

  • Authors : Kukkle PL; Center for Parkinson's Disease and Movement Disorders Manipal Hospital Bangalore India.; Parkinson's Disease and Movement Disorders Clinic Bangalore India.

Subjects: Apomorphine*/Apomorphine*/Apomorphine*/administration & dosage ; Apomorphine*/Apomorphine*/Apomorphine*/therapeutic use ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

  • Source: Movement disorders clinical practice [Mov Disord Clin Pract] 2023 Jun 26; Vol. 10 (9), pp. 1253-1267. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: eCollection Cited Medium: Internet ISSN: 2330-1619

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.

  • Authors : Kuo TT; National Defense Medical Center, Taipei 11490, Taiwan.; Chen YH

Subjects: Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/adverse effects ; Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/therapeutic use ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 28; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Green Spectrophotometric Platforms for Resolving Overlapped Spectral Signals of Recently Approved Antiparkinsonian Drug (Safinamide) in the Presence of Its Synthetic Precursor (4-Hydroxybenzaldehyde): Applying Ecological Appraisal and Comparative Statistical Studies.

  • Authors : El-Sayed HM; Zagazig University, Faculty of Pharmacy, Department of Analytical Chemistry, Zagazig 44519, Egypt.; El-Abassy OM

Subjects: Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/pharmacology ; Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/therapeutic use ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

  • Source: Journal of AOAC International [J AOAC Int] 2022 Dec 22; Vol. 106 (1), pp. 26-33.Publisher: Oxford University Press Country of Publication: England NLM ID: 9215446 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Parkinson's disease: Still waiting for a cure.

  • Authors : Kwok DK; Parkinson's Patient Advocate, Boulder, Colorado, USA.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnosis

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Jul; Vol. 17 (7), pp. e13898.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.

  • Authors : Ma J; Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.; Zhang G

Subjects: Supranuclear Palsy, Progressive*/Supranuclear Palsy, Progressive*/Supranuclear Palsy, Progressive*/drug therapy ; Supranuclear Palsy, Progressive*/Supranuclear Palsy, Progressive*/Supranuclear Palsy, Progressive*/physiopathology ; Semantics*

  • Source: Brain and behavior [Brain Behav] 2024 Jul; Vol. 14 (7), pp. e3606.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101570837 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Editorial & Opinion

Response to letter to the editor regarding "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries".

  • Authors : Antonini A; Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padua, Padua, Italy.; Chaudhuri KR

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnosis; Humans ; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/therapeutic use

  • Source: BMC neurology [BMC Neurol] 2024 Jul 30; Vol. 24 (1), pp. 266. Date of Electronic Publication: 2024 Jul 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  2,007 نتائج ل ""Antiparkinson Agents""